Your browser doesn't support javascript.
loading
GSK3-beta as a candidate therapeutic target in soft tissue sarcomas.
Verbeke, S; Perret, R; Chaire, V; Richard, E; Velasco, V; Giles, F; Cavalcante, L; Italiano, A.
Affiliation
  • Verbeke S; Sarcoma Unit, Institut Bergonié, 229 cours de l'Argonne, 33000, Bordeaux, France.
  • Perret R; INSERM, U1218, Bordeaux, France.
  • Chaire V; Department of Pathology, Institut Bergonié, Bordeaux, France.
  • Richard E; Sarcoma Unit, Institut Bergonié, 229 cours de l'Argonne, 33000, Bordeaux, France.
  • Velasco V; INSERM, U1218, Bordeaux, France.
  • Giles F; INSERM, U1218, Bordeaux, France.
  • Cavalcante L; Department of Pathology, Institut Bergonié, Bordeaux, France.
  • Italiano A; Actuate Therapeutics, Fort Worth, TX, USA.
J Hematol Oncol ; 14(1): 202, 2021 12 02.
Article in En | MEDLINE | ID: mdl-34857030
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma / Protein Kinase Inhibitors / Glycogen Synthase Kinase 3 beta Limits: Animals / Humans Language: En Journal: J Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2021 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma / Protein Kinase Inhibitors / Glycogen Synthase Kinase 3 beta Limits: Animals / Humans Language: En Journal: J Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2021 Document type: Article Affiliation country: